SHR-6508

N/A

Report date: 2024/12/19 16:46:09
NME

Base Information

Drug NameSHR-6508
Drug Alias NameSHR-6508
ClassificationSmall molecules
Mechanisms of ActionCalcium sensing receptor modulatorsprotein allosteric modulators
TargetsCalcium sensing receptor
Therapy Area/IndicationsHyperparathyroidism, SecondaryHyperparathyroidismRenal Insufficiency, Chronic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Hengrui Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHansoh Pharmaceutical Group Company LtdShanghai Hengrui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperparathyroidism, SecondaryHyperparathyroidismRenal Insufficiency, Chronic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A